Foundayo® was approved by the MHRA on 10th August 2026 and is now available in the UK.
Patients can now place an order and complete the required clinical assessment. All orders are clinically reviewed by our prescribing team, and Foundayo® will only be prescribed where the treatment is considered suitable.
Once an order has been clinically approved and processed, it can proceed for dispatch in line with our usual delivery process